Unusual Machines

UMAC · NYSE American

$16.38−$0.02 (−0.12%)TodayMarket closed ·
Prev close $16.40

UMAC analyst rating

BuyConsensus of 5 analysts over the last 12 months. 100% rate it a buy.
  • Strong buy0
  • Buy5
  • Hold0
  • Underperform0
  • Sell0

12-month price target · 10 analysts

Average $39.78 (+142.9% upside)

Low
$30.30
Now
$16.38
High
$47.25

Upgrades and downgrades

The latest rating actions, newest first

UMAC analyst upgrades, downgrades and rating actions
FirmDateActionRating
NeedhamOct 7, 2026MaintainsBuy
Piper SandlerAug 12, 2026InitiatesOverweight
NeedhamAug 6, 2026MaintainsBuy
HC Wainwright & Co.Jul 15, 2026InitiatesBuy
NeedhamJun 11, 2026MaintainsBuy
Roth CapitalJun 2, 2026MaintainsBuy
NeedhamMay 15, 2026MaintainsBuy
Roth CapitalMay 13, 2026InitiatesBuy
NeedhamApr 22, 2026MaintainsBuy
NeedhamApr 16, 2026MaintainsBuy

The case for and against

Updated Oct 14, 2026

Bull case

Unusual Machines is well positioned to benefit from a historic U.S. drone supercycle, with NDAA and FCC restrictions steadily shifting procurement toward domestic, compliant suppliers and leaving supply as the binding constraint into 2027. Its demand base appears broad and resilient, with Drone Dominance expected to be less than 30% of 2027 revenue, while C-UAS interceptors, Powerus, Fortem, and other programs create additional upside and reduce dependence on any single contract. Operational execution supports the thesis, as 2Q26 revenue reached $16.7M, up 687% Y/Y, gross margin improved to 34.7%, cash and short-term investments were about $316M with no debt, and the Orlando ramp points to 100,000 motors per month by year-end and a path toward profitability in 2027.

Bear case

Unusual Machines is exposed to an unattractive mix of execution, procurement, and supply-chain risk, making its growth thesis highly dependent on delayed and uncertain defense program awards. Its revenue outlook is lumpy because key OEM customers must win major small UAS contracts, yet there is no guarantee those awards arrive or ramp as expected, which could drive meaningful forecast cuts and a lower valuation multiple. The company also faces rising competition, raw-material dependence on third-party and China-linked inputs, and a difficult scale-up from 81 FTEs to a 500 target by YE 2026, all of which threaten margins, timely fulfillment, and profitability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.